[Transurethral columnar balloon dilation of the prostate for benign prostatic hyperplasia]

Area of Science:

• Urology
• Surgical Innovation
• Men's Health

Background:

• Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
• Effective treatment options for BPH are crucial for improving quality of life.
• Minimally invasive procedures are increasingly preferred for BPH management.

Purpose of the Study:

• To evaluate the clinical efficacy and surgical experience of transurethral columnar balloon dilation of the prostate (TUCBDP) for BPH treatment.
• To assess the safety and functional outcomes of TUCBDP.
• To identify patient suitability and potential complications associated with TUCBDP.

Main Methods:

• Retrospective analysis of clinical data from 265 BPH patients treated with TUCBDP between August 2016 and August 2019.
• Evaluation of surgical parameters including operation time and blood loss.
• Assessment of postoperative outcomes using International Prostate Symptom Score (IPSS), quality of life (QOL) score, maximum urinary flow rate (Qmax), postvoid residual urine (PVR), and sexual function scores (IIEF-5, EHS).

Main Results:

• Successful completion of TUCBDP in all cases with short operation times and minimal blood loss.
• Significant improvements observed in IPSS, QOL, Qmax, and PVR post-surgery (P < 0.05).
• No significant impact on sexual function (IIEF-5, EHS) in patients with sexual activity (P > 0.05), though retrograde ejaculation occurred in 4.45%.

Conclusions:

• TUCBDP demonstrates significant short-term clinical effectiveness for BPH treatment, characterized by a short procedure time and minimal bleeding.
• The procedure is well-suited for elderly patients and those concerned about preserving sexual function.
• Postoperative transient urinary incontinence requires attention, and intraoperative localization of prostatic protrusion may impact surgical outcomes.